Is the business good?
How good a business is HIMS?
Hims & Hers Health, Inc. keeps −6.0% of every revenue dollar as operating profit, against 12% for the median Drug Manufacturers - Specialty & Generic name.
−6.0%
Operating margin · Drug Manufacturers - Specialty & Generic median 12% · 12 months to Q2 2026
- Share count, year on year
- −9.8%
Share count, year on year · bought back, each share owns more of the company
- Gross margin
- 68%
Gross margin
| Year | Operating margin |
|---|---|
| FY2020 | −10% |
| FY2021 | −42% |
| FY2022 | −13% |
| FY2023 | −3.4% |
| FY2024 | 4.2% |
| FY2025 | 4.5% |
Details›
- Gross margin12 months to Q2 2026
- 68%
- Operating margin12 months to Q2 2026
- −6.0%
- Net margin12 months to Q2 2026
- −5.5%
- Free cash flow margin
- 2.4%
- Revenue, trailing twelve months
- $2.58B
- Free cash flow, trailing twelve months
- $62M
- Net income, trailing twelve months
- −$142M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Drug Manufacturers - Specialty & Generic
Ranks #16 of 28 by Smart Score